{"id":23162,"date":"2016-07-27T10:21:38","date_gmt":"2016-07-27T09:21:38","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=23162"},"modified":"2016-07-27T10:21:38","modified_gmt":"2016-07-27T09:21:38","slug":"la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/","title":{"rendered":"La seguretat en la preparaci\u00f3 i l&#8217;administraci\u00f3 de f\u00e0rmacs bioperillosos"},"content":{"rendered":"<p style=\"text-align: center;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-61.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-23211 aligncenter\" alt=\"farmacs-bioperillosos (6)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-61.jpg\" width=\"618\" height=\"174\" \/><\/a><\/p>\n<p style=\"text-align: left;\">Els Serveis de Farm\u00e0cia dels hospitals reben, emmagatzemen, distribueixen i moltes vegades preparen medicaments que s\u00f3n potencialment perillosos per a la salut dels treballadors del centre i acompanyants dels pacients. La preocupaci\u00f3 dels representants sindicals, de les Unitats B\u00e0siques de Prevenci\u00f3 de riscos laborals i dels responsables dels serveis ha crescut en els \u00faltims anys i s\u2019ha encetat un proc\u00e9s global de revisi\u00f3 de l\u2019estat de la q\u00fcesti\u00f3, enfocant com i amb qu\u00e8 s\u2019ha de protegir al personal. \u00c9s per aquesta ra\u00f3 que la <a href=\"http:\/\/www.scfarmclin.org\/\" target=\"_blank\" rel=\"noopener\">Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC)<\/a> i el COFB van organitzar una jornada de reflexi\u00f3, el 26 de maig, a la qual es van convidar experts en la mat\u00e8ria, personal d\u2019infermeria i caps de Servei de Farm\u00e0cia. Van coordinar l\u2019acte <strong>Tom\u00e0s Casasin<\/strong>, anterior vocal d\u2019Hospitals del Col\u00b7legi, i <strong>Julio Mart\u00ednez<\/strong>, president de la SCFC.<\/p>\n<p><b>Joan A. Schoeneneberger<\/b>, un dels ponents de la jornada, resumeix els <strong>aspectes m\u00e9s destacats<\/strong>:<\/p>\n<figure id=\"attachment_23186\" aria-describedby=\"caption-attachment-23186\" style=\"width: 298px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-1.jpg\"><img decoding=\"async\" class=\" wp-image-23186   \" alt=\"farmacs-bioperillosos (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-1.jpg\" width=\"298\" height=\"199\" \/><\/a><figcaption id=\"caption-attachment-23186\" class=\"wp-caption-text\">Xavier Guardino (INSHT)<\/figcaption><\/figure>\n<div class=\"box shadow\">La sessi\u00f3, que va aplegar un nombr\u00f3s p\u00fablic professional, es va iniciar amb la presentaci\u00f3 del tema i dels ponents per part del president de la SCFC el <b>Julio Martinez<\/b>. El primer ponent, <b>Xavier Guardino<\/b>, enginyer qu\u00edmic i director del Departament d\u2019Informaci\u00f3 i Documentaci\u00f3 del Centro Nacional de Condiciones de Trabajo de <a href=\"http:\/\/www.insht.es\/portal\/site\/Insht\/;VAPCOOKIE=9fqnXGJRGG4WGhQFGp3lhmCl5XWDHGG0bL0nS703D8YLDncLDQKy!1169818689!571557752\">l\u2019Instituto Nacional de Seguridad e Higiene en el Trabajo<\/a> (INSHT), va explicar la recent \u201c<b>Nota T\u00e8cnica de Prevenci\u00f3 1051\u201d <\/b>del INSHT, en la que es posen al dia les recomanacions dels organismes oficials sobre la q\u00fcesti\u00f3. Va fer un rep\u00e0s hist\u00f2ric del problema de la contaminaci\u00f3 dels espais de treball hospitalaris amb restes de citost\u00e0tics, del context legal i normatiu en el qual ens movem actualment i de com a parer seu s\u2019hauria de refor\u00e7ar la lluita contra aquesta contaminaci\u00f3 amb noves mesures.<\/p>\n<p>[caption id=\"attachment_23188\" align=\"alignright\" width=\"199\"]<a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-3.jpg\"><img decoding=\"async\" class=\" wp-image-23188  \" alt=\"farmacs-bioperillosos (3)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-3.jpg\" width=\"199\" height=\"298\" \/><\/a> Jose Luis Poveda (Hospital La Fe de Val\u00e8ncia)[\/caption]<\/p>\n<p>El seg\u00fcent ponent, <b>Jose Luis Poveda<\/b>, cap de Servei de Farm\u00e0cia de l\u2019Hospital La Fe de Val\u00e8ncia, va presentar els resultats de l\u2019aplicaci\u00f3 d\u2019un ambici\u00f3s i alhora exit\u00f3s programa que tenia com a objectiu reduir de forma dr\u00e0stica la pres\u00e8ncia de restes de f\u00e0rmacs perillosos als diferents recintes i \u00e0mbits de treball. Un dels aspectes m\u00e9s destacats del pla que l\u2019Hospital La Fe de Val\u00e8ncia va aplicar va ser la <b>utilitzaci\u00f3 de sistemes de transfer\u00e8ncia tancats en la preparaci\u00f3 d\u2019injectables junt amb altres mesures t\u00e8cniques i organitzatives<\/b> que va explicar de forma detallada. Tamb\u00e9 va assenyalar que els objectius es van assolir despr\u00e9s de bastants mesos d\u2019intens treball, amb un ampli programa de formaci\u00f3 del personal i la necess\u00e0ria demostraci\u00f3 amb metodologia cient\u00edfica de l&#8217;efectivitat de les mesures endegades.<\/p>\n<p>[caption id=\"attachment_23189\" align=\"alignleft\" width=\"179\"]<a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-4.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-23189    \" alt=\"farmacs-bioperillosos (4)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-4.jpg\" width=\"179\" height=\"268\" \/><\/a> Yvonne Fern\u00e1ndez (Fundaci\u00f3 Puigvert)[\/caption]<\/p>\n<p>Seguidament <b>Yvonne Fern\u00e1ndez<\/b>, responsable de la unitat de Prevenci\u00f3 de Riscos Laborals de la Fundaci\u00f3 Puigvert, va fer un rep\u00e0s exhaustiu dels <b>Equips de Protecci\u00f3 Individual (EPIs)<\/b> disponibles en l\u2019\u00e0mbit de la preparaci\u00f3 de medicaments perillosos i de les caracter\u00edstiques que s\u2019han de tenir en consideraci\u00f3 quan es seleccionen. Els EPIs s\u00f3n un complement indispensable a utilitzar junt amb la resta de tecnologies a l\u2019abast com les cabines de seguretat biol\u00f2gica o els sistemes de transfer\u00e8ncia tancats.<\/p>\n<p>La segona part de la sessi\u00f3 es va iniciar amb la intervenci\u00f3 d\u2019<b>Anna de Arriba<\/b>, infermera de l\u2019Hospital de Dia IOB Quir\u00f3n Barcelona, que va explicar com aborda l\u2019administraci\u00f3 de medicaments perillosos el personal d\u2019infermeria de les unitats de tractament. De la seva intervenci\u00f3 cal destacar que <b>les preparacions medicamentoses que arriben del Servei de Farm\u00e0cia han de venir munits d\u2019equips purgats amb solucions netes i que en l\u2019administraci\u00f3 s\u2019utilitzen equips amb diferents ports que un cop connectats a les preparacions ja no s\u2019han de desconnectar<\/b>.<\/p>\n<p>[caption id=\"attachment_23190\" align=\"alignright\" width=\"298\"]<a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-5.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-23190  \" alt=\"farmacs-bioperillosos (5)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-5.jpg\" width=\"298\" height=\"199\" \/><\/a> Anna de Arriba (Hospital de Dia IOB Quir\u00f3n Barcelona)[\/caption]<\/p>\n<p>[caption id=\"attachment_23207\" align=\"alignleft\" width=\"286\"]<a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-8.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-23207 \" alt=\"farmacs-bioperillosos (8)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-8.jpg\" width=\"286\" height=\"190\" \/><\/a> Joan A. Schoeneneberger (Hospital Arnau de Vilanova, Lleida) i Raquel L\u00f3pez (Fundaci\u00f3 Puigvert)[\/caption]<\/p>\n<p>A continuaci\u00f3 els responsables de Servei de Farm\u00e0cia, <b>Raquel L\u00f3pez<\/b> (Fundaci\u00f3 Puigvert) i <b>Joan A. Schoeneneberger <\/b>(Hospital Arnau de Vilanova, Lleida), van exposar el seu punt de vista sobre la q\u00fcesti\u00f3 a debat. \u00c9s un fet que tant hospitals monogr\u00e0fics com La Cl\u00ednica Puigvert com hospitals generals com l\u2019Arnau de Vilanova gestionen medicaments perillosos, considerant com a tals els que figuren a la llista del\u00a0Instituto Nacional para la Seguridad y Salud Ocupacional (NIOSH). <b>Els centres tenen la missi\u00f3 de disposar d\u2019informaci\u00f3 actualitzada sobre el grau de perillositat dels medicaments que gestiona i assegurar que els que ho siguin es manipulen adequadament per tal d\u2019evitar qualsevol contacte dels treballadors, pacients i acompanyants<\/b>. Amb aquest objectiu <b>\u00e9s convenient dissenyar plans especials per a la utilitzaci\u00f3 de medicaments perillosos, plans que hauran de ser impulsats per comissions multidisciplin\u00e0ries i abordar tots i cadascun dels punts sensibles<\/b>: la recepci\u00f3, l\u2019emmagatzemament, la preparaci\u00f3 per a l\u2019administraci\u00f3, la dispensaci\u00f3 i la mateixa administraci\u00f3.<\/p>\n<p>Finalment, es va discutir el tema de la perillositat dels medicaments en investigaci\u00f3 que moltes vegades \u00e9s molt desconeguda i que obliga a investigadors u personal de les \u00e0rees implicades a aplicar el principi de la prud\u00e8ncia.<\/p>\n<p><span style=\"color: #888888;\">Com a conclusi\u00f3 de la jornada es despr\u00e8n la <b>necessitat d\u2019estudiar i avaluar les diferents opcions tecnol\u00f2giques disponibles per millorar la seguretat del personal\u00a0 que manipula medicaments perillosos<\/b>, amb especial inter\u00e8s pel que fa a l\u2019\u00fas de sistemes de transfer\u00e8ncia tancats en la preparaci\u00f3 de medicaments injectables.<\/span> \u00a0<\/div>\n<p style=\"text-align: center;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-2.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-23187 aligncenter\" alt=\"farmacs-bioperillosos (2)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/farmacs-bioperillosos-2.jpg\" width=\"486\" height=\"299\" \/><\/a><\/p>\n<p align=\"right\"><strong>Amb la col\u00b7laboraci\u00f3 de:\u00a0<\/strong><\/p>\n<p align=\"right\"><a href=\"http:\/\/www.bd.com\/es\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright  wp-image-23166\" alt=\"BECTON_DICKINSON\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/BECTON_DICKINSON.jpg\" width=\"120\" height=\"54\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Els Serveis de Farm\u00e0cia dels hospitals reben, emmagatzemen, distribueixen i moltes vegades preparen medicaments que s\u00f3n potencialment perillosos per a la salut dels treballadors del centre i acompanyants dels pacients. La preocupaci\u00f3 dels representants sindicals, de les Unitats B\u00e0siques de Prevenci\u00f3 de riscos laborals i dels responsables dels serveis ha [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":23187,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[480,2446,2447,285,2448],"class_list":["post-23162","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-farmacia-hospitalaria","tag-farmacs-bioperillosos","tag-medicaments-bioperillosos","tag-scfc","tag-servei-de-farmacia-dhospital"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La seguretat en la preparaci\u00f3 i l&#039;administraci\u00f3 de f\u00e0rmacs bioperillosos - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La seguretat en la preparaci\u00f3 i l&#039;administraci\u00f3 de f\u00e0rmacs bioperillosos - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Els Serveis de Farm\u00e0cia dels hospitals reben, emmagatzemen, distribueixen i moltes vegades preparen medicaments que s\u00f3n potencialment perillosos per a la salut dels treballadors del centre i acompanyants dels pacients. La preocupaci\u00f3 dels representants sindicals, de les Unitats B\u00e0siques de Prevenci\u00f3 de riscos laborals i dels responsables dels serveis ha [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-07-27T09:21:38+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"La seguretat en la preparaci\u00f3 i l&#8217;administraci\u00f3 de f\u00e0rmacs bioperillosos\",\"datePublished\":\"2016-07-27T09:21:38+00:00\",\"dateModified\":\"2016-07-27T09:21:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/\"},\"wordCount\":1006,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"farm\u00e0cia hospital\u00e0ria\",\"f\u00e0rmacs bioperillosos\",\"medicaments bioperillosos\",\"SCFC\",\"servei de farm\u00e0cia d'hospital\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/\",\"name\":\"La seguretat en la preparaci\u00f3 i l'administraci\u00f3 de f\u00e0rmacs bioperillosos - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-07-27T09:21:38+00:00\",\"dateModified\":\"2016-07-27T09:21:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La seguretat en la preparaci\u00f3 i l&#8217;administraci\u00f3 de f\u00e0rmacs bioperillosos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La seguretat en la preparaci\u00f3 i l'administraci\u00f3 de f\u00e0rmacs bioperillosos - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/","og_locale":"ca_ES","og_type":"article","og_title":"La seguretat en la preparaci\u00f3 i l'administraci\u00f3 de f\u00e0rmacs bioperillosos - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Els Serveis de Farm\u00e0cia dels hospitals reben, emmagatzemen, distribueixen i moltes vegades preparen medicaments que s\u00f3n potencialment perillosos per a la salut dels treballadors del centre i acompanyants dels pacients. La preocupaci\u00f3 dels representants sindicals, de les Unitats B\u00e0siques de Prevenci\u00f3 de riscos laborals i dels responsables dels serveis ha [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-07-27T09:21:38+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"La seguretat en la preparaci\u00f3 i l&#8217;administraci\u00f3 de f\u00e0rmacs bioperillosos","datePublished":"2016-07-27T09:21:38+00:00","dateModified":"2016-07-27T09:21:38+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/"},"wordCount":1006,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#primaryimage"},"thumbnailUrl":"","keywords":["farm\u00e0cia hospital\u00e0ria","f\u00e0rmacs bioperillosos","medicaments bioperillosos","SCFC","servei de farm\u00e0cia d'hospital"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/","url":"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/","name":"La seguretat en la preparaci\u00f3 i l'administraci\u00f3 de f\u00e0rmacs bioperillosos - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-07-27T09:21:38+00:00","dateModified":"2016-07-27T09:21:38+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/27\/la-seguretat-en-la-preparacio-i-ladministracio-de-farmacs-bioperillosos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"La seguretat en la preparaci\u00f3 i l&#8217;administraci\u00f3 de f\u00e0rmacs bioperillosos"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Els Serveis de Farm\u00e0cia dels hospitals reben, emmagatzemen, distribueixen i moltes vegades preparen medicaments que s\u00f3n potencialment perillosos per a la salut dels treballadors del centre i acompanyants dels pacients. La preocupaci\u00f3 dels representants sindicals, de les Unitats B\u00e0siques de Prevenci\u00f3 de riscos laborals i dels responsables dels serveis ha [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/23162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=23162"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/23162\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=23162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=23162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=23162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}